Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Biomarkers Predicting Responsiveness to Rituximab in Follicular Lymphoma

NCT01150643 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.

NCT NCT01150643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01150643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Biomarkers Predicting Responsiveness to Rituximab in Follicular Lymphoma
Lead sponsor
Eastern Cooperative Oncology Group
Phase
Observational
Overall status
Completed
Start date
December 6, 2010
Completion date
January 6, 2011
Enrollment
559 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma